Back to Search
EE-LENG DEJESUS, DO
DO
Family Medicine Physician
NPI: 1558620260IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
70873(GA)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
LAKE ERIE COLLEGE OF OSTEOPATHIC MEDICINE, ERIE
Class of 2012
Research & Publications (20)
Simplification of antiretroviral therapy to a single-tablet regimen consisting of efavirenz, emtricitabine, and tenofovir disoproxil fumarate versus unmodified antiretroviral therapy in virologically suppressed HIV-1-infected patients.
PMID 19357529·J Acquir Immune Defic Syndr·2009
4-observational
Safety and efficacy of enfuvirtide in combination with darunavir-ritonavir and an optimized background regimen in treatment-experienced human immunodeficiency virus-infected patients: the below the level of quantification study.
PMID 18809940·Antimicrob Agents Chemother·2008
3-trial
Use of Dronabinol Improves Appetite and Reverses Weight Loss in HIV/AIDS-Infected Patients.
PMID 17538000·J Int Assoc Physicians AIDS Care (Chic)·2007
8-other
Abacavir versus zidovudine combined with lamivudine and efavirenz, for the treatment of antiretroviral-naive HIV-infected adults.
PMID 15472858·Clin Infect Dis·2004
3-trial
Once-daily versus twice-daily lamivudine, in combination with zidovudine and efavirenz, for the treatment of antiretroviral-naive adults with HIV infection: a randomized equivalence trial.
PMID 15307010·Clin Infect Dis·2004
3-trial
Valacyclovir for the suppression of recurrent genital herpes in human immunodeficiency virus-infected subjects.
PMID 14513421·J Infect Dis·2003
3-trial
Comparison of once-daily fosamprenavir boosted with either 100 or 200 mg of ritonavir, in combination with abacavir/lamivudine: 96-week results from COL100758.
PMID 19320570·AIDS Res Hum Retroviruses·2009
4-observational
A randomized, controlled trial of initial anti-retroviral therapy with abacavir/lamivudine/zidovudine twice-daily compared to atazanavir once-daily with lamivudine/zidovudine twice-daily in HIV-infected patients over 48 weeks (ESS100327, the ACTION Study).
PMID 19358725·AIDS Res Ther·2009
8-other
Select updates from the 16th CROI: treatment-related cardiovascular risk, pharmacokinetic issues, and interleukin-2 use.
PMID 19388184·AIDS Read·2009
8-other
Modulation of K65R selection by zidovudine inclusion: analysis of HIV resistance selection in subjects with virologic failure receiving once-daily abacavir/lamivudine/zidovudine and tenofovir DF (study COL40263).
PMID 19563238·AIDS Res Hum Retroviruses·2009
3-trial
Antiretroviral therapy update from the 48th ICAAC/46th IDSA annual meeting.
PMID 19209453·AIDS Read·2009
8-other
Proof of activity with AMD11070, an orally bioavailable inhibitor of CXCR4-tropic HIV type 1.
PMID 19193109·Clin Infect Dis·2009
3-trial
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial.
PMID 19647866·Lancet·2009
3-trial
Safety, pharmacokinetics, and antiretroviral activity of multiple doses of ibalizumab (formerly TNX-355), an anti-CD4 monoclonal antibody, in human immunodeficiency virus type 1-infected adults.
PMID 19015347·Antimicrob Agents Chemother·2009
2-rct
Maraviroc for previously treated patients with R5 HIV-1 infection.
PMID 18832244·N Engl J Med·2008
3-trial
The 3-year renal safety of a tenofovir disoproxil fumarate vs. a thymidine analogue-containing regimen in antiretroviral-naive patients.
PMID 18832879·AIDS·2008
3-trial
Antiretroviral treatment update from the 17th International AIDS Conference.
PMID 19062402·AIDS Read·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 55981 E COLFAX AVE
STRASBURG, CO 80136 - Phone
- (719) 632-5700
Quick Facts
- NPI
- 1558620260
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 14
- Publications
- 20
Are you this provider?
Claim Your Profile